Physicians' Academy for Cardiovascular Education

Statin Landmark Trials Across the Spectrum of Risk: Primary CV Prevention

Slides (presentation) - Dec. 22, 2012

Slide lecture program (8 slides): View & Download

  1. Over Time Additional Risk Factors Can Progress
  2. ASCOT LLA Trial of Statin in Hypertensive Patients With Additional Risk Factors
  3. ASCOT LLA Primary End Point: Nonfatal MI and Fatal CHD
  4. ASCOT LLA Secondary End Point: Fatal and Nonfatal Stroke
  5. HPS: Effects of Statin on Major Coronary Events and Stroke in Diabetic and Nondiabetic Patients
  6. CARDS: Effect of Atorvastatin on the Primary End Point—Major CV Events Including Stroke
  7. CARDS: Component End Points
  8. JUPITER Trial of Statin in People With Elevated CRP: Primary End Point

Click on slides to preview

Download slides below

Statin Landmark Trials Across the Spectrum of Risk
Over Time Additional Risk Factors Can Progress
ASCOT LLA Trial of Statin in Hypertensive Patients
ASCOT LLA Primary End Point:Nonfatal MI and Fatal CHD
ASCOT LLA Secondary End Point: Fatal and Nonfatal Stroke
HPS: Effects of Statin on Major Coronary Events and Stroke
CARDS: Effect of Atorvastatin on the Primary End Point
CARDS: Component End Points
JUPITER Trial of Statin in People With Elevated CRP

Share this page with your colleagues and friends: